Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-25 @ 5:06 AM
NCT ID:
NCT05663827
Eligibility Criteria:
Inclusion Criteria:
* Patients diagnosed with hematologic disorder
Exclusion Criteria:
* Those who are not applicable of receiving Ruxolitinib as immunodeficiency-modulation therapy
* Those who are actively encountering acute infectious illness
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
3 Months
Maximum Age:
30 Years
Study:
NCT05663827
Study Brief:
Protocol Section:
NCT05663827